This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on October 30, 2024, is a Firm Fixed Price Delivery Order valued at $1,180.74 with a completion date of October 31, 2024. The contract covers the procurement of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with no set-aside designation. AmerisourceBergen also holds a significant...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a Delivery Order with a Firm Fixed Price of $2,190.63, and has an Ultimate Completion Date of June 9, 2025. The award was made by the Defense Logistics Agency, a Defense agency, on June 6, 2025. This contract is not set-aside and is open to full and open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MYFEMBREE, a specialty medication, and has a ceiling value of $1,632.41. The contract is a firm fixed-price Indefinite Delivery Vehicle (IDV) with a period of performance through January 2025. The contract is not designated as a set-aside and was awarded through open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,542.20, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of MYFEMBREE, a medication used to treat uterine fibroids, with a ceiling value of $2,705.81 and an ultimate completion date of May 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $12,570.22, is for the delivery of pharmaceutical products including medications, medical supplies, and devices. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,676.93, is for the delivery of YUVAFEM 10 MCG vaginal inserts. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $5,686.84, for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2022. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,939.74 Firm Fixed Price Delivery Order contract has a completion date of February 7, 2025 and provides for the delivery of pharmaceutical products and medical supplies to support military and federal healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,438.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUVAFEM 10 MCG vaginal inserts and has an ultimate completion date of October 11, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...